SCHEMBL8970975

SCHEMBL8970975

Nc1ncc2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)c2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 2/20 0.60
▸ ADORA1 P30542 2/20 0.60
▸ PDE2A O00408 1/20 0.60
▸ ADORA2A P29274 1/20 0.60
▸ ADRA1A P35348 1/20 0.60
▸ PDE4D Q08499 1/20 0.60
▸ PDE3A Q14432 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ CD99 P14209 1/20 0.53
▸ SLC29A1 Q99808 5/20 0.52
▸ LMNA P02545 2/20 0.51
▸ GMNN O75496 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ DNMT1 P26358 1/20 0.51
▸ THPO P40225 1/20 0.51
▸ MTOR P42345 1/20 0.51
▸ HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8970966 1.00 ADORA3 (0.60) ADORA3ADORA1PDE2AADORA2AADRA1A
SCHEMBL1494485 0.89 KDM4E (0.69) ADORA3ADORA1ADORA2AKDM4EPKM
SCHEMBL1494490 0.89 KDM4E (0.69) ADORA3ADORA1ADORA2AKDM4EPKM
SCHEMBL23710624 0.89 KDM4E (0.69) ADORA3ADORA1ADORA2AKDM4EPKM
SCHEMBL29471286 0.89 KDM4E (0.69) ADORA3ADORA1ADORA2AKDM4EPKM
SCHEMBL25342616 0.83 KDM4E (0.56) ADORA3ADORA1ADORA2AKDM4EPKM
SCHEMBL8610836 0.82 KDM4E (0.53) ADORA3ADORA1PDE2AADORA2AADRA1A
SCHEMBL8610847 0.82 KDM4E (0.53) ADORA3ADORA1PDE2AADORA2AADRA1A
SCHEMBL24233629 0.81 ADORA2A (0.80) ADORA3ADORA1PDE2AADORA2AADRA1A
SCHEMBL12667516 0.81 ADORA2A (0.80) ADORA3ADORA1PDE2AADORA2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417999-B1 Antiviral compounds WELLCOME FOUND (GB) 1996-03-13 — — EP claimed
US-5420115-A Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides BURROUGHS WELLCOME CO. (US) 1995-05-30 — — US claimed
EP-0417999-A1 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1991-03-20 — — EP claimed
EP-0417999-B1 Antiviral compounds WELLCOME FOUND (GB) 1996-03-13 — — EP disclosed
EP-0671410-A1 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1995-09-13 — — EP disclosed
US-5420115-A Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides BURROUGHS WELLCOME CO. (US) 1995-05-30 — — US disclosed
US-5420115-A Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides BURROUGHS WELLCOME CO. (US) 1995-05-30 — — US disclosed
US-5175274-A Treatment of HIV infections BURROUGHS WELLCOME CO. (US) 1992-12-29 — — US disclosed
EP-0285432-B1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-11 — — EP disclosed
EP-0417999-A1 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1991-03-20 — — EP disclosed
EP-0285432-A2 Therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1988-10-05 — — EP disclosed
Send feedback